Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis
- 347 Downloads
There has been increased interest in the role of anti-Proteus antibodies in the aetiology of rheumatoid arthritis (RA) and whether chemotherapeutic agents active against Proteus species might reduce the risk and/or exacerbations of RA. We examined the in vitro antibacterial effects of ten different silver preparations which were either ionic silver [Ag(I)] solutions or nanoparticulate silver (NPS) (Ag0) suspensions against ATCC and two wild (clinical) strains of Proteus. The data establish the low minimum inhibitory concentration and minimum bactericidal concentration of all the silver formulations tested against these four Proteus strains. In a pilot study, a potent NPS preparation ex vivo showed long-lasting anti-Proteus activity in a normal human volunteer.
KeywordsProteus Rheumatoid arthritis Silver antimicrobials Nanoparticulate silver
We are indebted to A White and J Petty for advice and assistance with silver analyses; to M Baharevs (Sydney) and Academician V Nesterov (Omsk) for assistance and advice in using the MetAtron monitor; to Dr G Maas (USA) for providing Meso Silver; and to D Butters for preparing the final MS. The Brisbane Holland Park Lions Club and W Whitney (and friends) helped fund the NPS studies.
- Dayanand S, Dayanand A, Sreedhar B, Dastager SG (2010) Antimicrobial activity of silver nanoparticles synthesized from novel Streptomyces species. Dig J Nanomater Bios 5:447–451Google Scholar
- Ebringer A (2012) Rheumatoid arthritis and Proteus. Springer, London, p 223Google Scholar
- Laroo H (2013) Colloidal nanosilver—its production method, properties, standards, and its bio-efficacy as an inorganic antibiotic. J Phys Chem Biophys (Omicsonline.org ISSN: 2161-0398)Google Scholar
- Liu J, Sonshine DA, Shervani S, Hurt RH (2010) Controlled release of biologically active silver from nanosilver surfaces. NANO 4:6903–6913Google Scholar
- Lo B (2010) Ethical issues in clinical research: a practical guide. Walters Kluwer, Philadelphia, p 292Google Scholar
- Rashid T, Ebringer A (2011) Rheumatoid arthritis is caused by asymptomatic Proteus urinary tract infections. In: Nikibakhsh A (ed) Clinical management of complicated urinary tract infection. In-Tech. vol 11Google Scholar
- Rashid T, Tiwana H, Wilson C, Ebringer A (2001) Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. Israeli Med Assoc J (IMAJ) 3:675–680Google Scholar
- Sylver N (2009) Handbook of frequency therapy. Desert Gate, Phoenix, p 732Google Scholar
- Varner K, El-Badaway A, Feldhake D, Venkatapathy R (2010) State of the science literature review: everything nanosilver and more. US Environmental Protection Agency, Washington DC, p 363Google Scholar
- Whitehouse M, Butters D, Vernon-Roberts B (2013) Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (MyocrysinR) and metallic silver. Inflammopharmacology 21:291–300PubMedCrossRefGoogle Scholar